STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Scandinavian Clinical Nutrition (OSE:SCN): Recent tests on human cells show that SCN’s patented substance NGNA/N5G has good antiviral effect on several viruses that affect humans, especially the rhinovirus, which is the most common cause for cold symptoms. The substance also has a strong protective effect against severe complications from the influenza virus.
